Table 3.

Bivariable and Multivariable Linear Regression Results for QuickDASH Scores

	Unadjusted Parameter Estimate	95% CI	p	Adjusted Parameter Estimate	95% CI	p
Black	7.33	3.59, 11.09	<0.001	4.10	0.18, 8.01	0.04
BMI	0.74	0.52, 0.95	<0.001	0.70	0.48, 0.92	<0.001
Age	0.12	−0.01, 0.26	0.08	0.12	−0.04, 0.28	0.13
More than HS Education	−4.92	−8.31, −1.53	0.005	−2.72	−6.62, 0.80	0.13
Cancer Stage at Diagnosis	0.30	−1.66, 2.27	0.76	−0.58	−3.18, 2.02	0.66
Months Since Diagnosis	−0.014	−0.05, 0.22	0.46	−0.03	−0.07, 0.007	0.10
Bilateral Surgery	−1.10	−5.89, 3.69	0.65	−1.82	−6.55, 2.922	0.45
Lumpectomy	−0.53	−3.48, 2.43	0.73	−0.14	−3.89, 3.61	0.94
Mastectomy	−1.21	−4.04, 1.63	0.40	−1.35	−6.43, 3.73	0.60
Chemotherapy	−0.77	−3.56, 2.02	0.59	0.26	−3.21, 3.74	0.88
Radiation	−0.58	−3.67, 2.51	0.71	−1.69	−5.60, 2.22	0.40
Reconstruction	−0.22	−3.24, 2.80	0.89	1.83	−2.41, 6.09	0.40
Lymph Nodes Removed	0.15	−0.03, 0.33	0.10	0.17	−0.05, 0.39	0.13
AI in Past Month
None (ref)	--	--	--	--	--	--
Arimidex (Anastrazole)	−3.80	−7.97, 0.38	0.08	−3.97	−8.06, 0.13	0.06
Aromasin (Exemestane)	−1.00	−9.13, 7.11	0.81	2.11	−5.86, 10.08	0.60
Femara (Letrezole)	−0.51	−6.13, 5.11	0.86	−1.50	−7.05, 4.05	0.60

For final model: R²=0.12; Adjusted R²=0.09